New Data Demonstrate Efficacy Of Aerius R Desloratadine In Reducing Allergy Symptoms In Patients With Intermittent Allergic Rhinitis

New data presented at the XXVII Congress of the European Academy of Allergology and Clinical Immunology (EAACI) in Barcelona, Spain, demonstrate AERIUS (desloratadine) significantly reduces allergy symptoms, including nasal congestion, sneezing, rhinorrhea, nasal pruritus and ocular pruritus, in patients with intermittent allergic rhinitis (IAR) who experience symptoms lasting less than four days per week or less than four weeks per year. ...

Write comment to this article:

Subject:

Name:

email or site:

Code: